| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.39 | 0.03 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.37 | 0.04 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.35 | 0.04 |